Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

about

Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention

P2860

Q37628495-B711F9D4-14F9-401E-A1EB-3562CA0EAB16 Q58696710-E6563452-F3A1-4372-A708-276745660534

P2860

Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

Item

http://www.wikidata.org/entity/Q36029715

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@ast

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@en

type

Item

label

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@ast

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@en

prefLabel

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@ast

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@en

P1476

Impact of Short-term 1,25-Dihy ...... Erlotinib against Oral Cancer.

@en

P2093

Amritha Suresh

http://www.w3.org/2001/XMLSchema#string

Candace S Johnson

http://www.w3.org/2001/XMLSchema#string

Katelyn D Bothwell

http://www.w3.org/2001/XMLSchema#string

Mihai Merzianu

http://www.w3.org/2001/XMLSchema#string

Moni A Kuriakose

http://www.w3.org/2001/XMLSchema#string

Mukund Seshadri

http://www.w3.org/2001/XMLSchema#string

Pamela A Hershberger

http://www.w3.org/2001/XMLSchema#string

Tatiana Shaurova

http://www.w3.org/2001/XMLSchema#string

P2860

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy

Dose translation from animal to human studies revisited

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo.

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.

Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.

Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

P304

765-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-14-0454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26100522

http://www.w3.org/2001/XMLSchema#string

P932

4560661

http://www.w3.org/2001/XMLSchema#string

Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

about

P2860

P2860

Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932